Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.

Autor:	Snyder HM; Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL, USA. Electronic address: hsnyder@alz.org., Ahles T; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Calderwood S; Radiation Oncology, Harvard University Medical School, Boston, MA, USA., Carrillo MC; Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL, USA., Chen H; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA., Chang CH; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh Medical School, Pittsburgh, PA, USA; Clinical and Translational Science, University of Pittsburgh Medical School, Pittsburgh, PA, USA., Craft S; Division of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest University of Medicine, Winston-Salem, NC, USA., De Jager P; Geriatric Research Education and Clinical Center, VA Boston HealthCare System, Boston, MA, USA., Driver JA; Division of Aging, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard University Medical School, Boston, MA, USA., Fillit H; Scientific Affairs, Alzheimer's Drug Discovery Foundation, New York, NY, USA., Knopman D; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Lotze M; Departments of Surgery, Immunology and Bioengineering, University of Pittsburgh Medical School, Pittsburgh, PA, USA., Tierney MC; Department of Family and Community Medicine, Sunnybrook Health Science Center, Toronto, Ontario, Canada., Petanceska S; Division of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA., Saykin A; Department of Radiology, Indiana University School of Medicine, Indianapolis, IN, USA., Seshadri S; Division of Neurology, Boston University Medical School, Boston, MA, USA., Shineman D; Scientific Affairs, Alzheimer's Drug Discovery Foundation, New York, NY, USA., Ganguli M; Professor of Psychiatry, Neurology, and Epidemiology, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA, USA.
Jazyk:	angličtina
Zdroj:	Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2017 Mar; Vol. 13 (3), pp. 267-273. Date of Electronic Publication: 2016 Dec 18.
DOI:	10.1016/j.jalz.2016.11.002
Abstrakt:	Recent population studies suggest an intriguing inverse relationship between several types of cancer and neurodegenerative diseases, including Alzheimer's disease. Understanding the intersection of the underlying biology for these two distinct families of diseases with one another may offer novel approaches to identify new therapeutic approaches and possible opportunities to repurpose existing drug candidates. The Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened a one-day workshop to delve into this discussion. Workshop participants outlined research focus areas, potential collaborations, and partnerships for future action. (Copyright © 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu